Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Valerie A Ruff"'
Autor:
Jahangir Alam, Valerie A Ruff, Thomas E. Melby, David W. Dempster, Kathleen A. Taylor, Hua Zhou
Publikováno v:
Journal of Bone and Mineral Research. 33:627-633
Previously, we reported on bone histomorphometry, biochemical markers, and bone mineral density distribution after 6 and 24 months of treatment with teriparatide (TPTD) or zoledronic acid (ZOL) in the SHOTZ study. The study included a 12-month primar
Autor:
Sudhaker D Rao, Robert R. Recker, Valerie A Ruff, Jahangir Alam, Kathleen A. Taylor, David L. Kendler, Hua Zhou, Christopher Recknor, Jacques P. Brown, John H. Krege, Robert Lindsay, David W Dempster, Thomas E. Melby, Paul D. Miller, E. Michael Lewiecki
Publikováno v:
Journal of Bone and Mineral Research. 33:298-306
There has been renewed interest of late in the role of modeling-based formation (MBF) during osteoporosis therapy. Here we describe early effects of an established anabolic (teriparatide) versus antiresorptive (denosumab) agent on remodeling-based fo
Autor:
Boris Janos, Robert R. Recker, Jahangir Alam, John H. Krege, David W. Dempster, Paul D. Miller, David L. Kendler, Jacques P. Brown, Sudhaker D Rao, E. Michael Lewiecki, Hua Zhou, Christopher Recknor, Kathleen A. Taylor, Robert Lindsay, Valerie A Ruff
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 101:1353-1363
Context: Denosumab-induced PTH elevation may stimulate early bone formation. Objective: Our objective was to evaluate whether denosumab-induced changes of intact PTH (iPTH) result in early anabolic effects according to histomorphometry and bone turno
Autor:
Barbara M. Misof, Jahangir Alam, David W. Dempster, Eleftherios P. Paschalis, Paul Roschger, Kathleen A. Taylor, Hua Zhou, Klaus Klaushofer, Valerie A Ruff
Publikováno v:
Journal of Bone and Mineral Research. 31:1527-1535
The Skeletal Histomorphometry in Patients on Teriparatide or Zoledronic Acid Therapy (SHOTZ) study assessed the progressive effects of teriparatide (TPTD) and zoledronic acid (ZOL) on bone remodeling and material properties in postmenopausal women wi
Autor:
David W. Dempster, Valerie A Ruff, Robert R. Recker, Eileen R Gallagher, David A. Hanley, Grattan Woodson, Sudhaker D Rao, Neil Binkley, Michael A. Bolognese, Jahangir Alam, David L. Kendler, Hua Zhou, Christopher Recknor, Paul D. Miller, Robert Lindsay, E. Michael Lewiecki, Kathleen A. Taylor, Jacques P. Brown
Publikováno v:
Journal of Bone and Mineral Research. 31:1429-1439
Previously, we reported the effects of teriparatide (TPTD) and zoledronic acid (ZOL) on bone formation based on biochemical markers and bone histomorphometry of the cancellous envelope at month 6 in postmenopausal women with osteoporosis who particip
Autor:
David W, Dempster, Hua, Zhou, Robert R, Recker, Jacques P, Brown, Christopher P, Recknor, E Michael, Lewiecki, Paul D, Miller, Sudhaker D, Rao, David L, Kendler, Robert, Lindsay, John H, Krege, Jahangir, Alam, Kathleen A, Taylor, Thomas E, Melby, Valerie A, Ruff
Publikováno v:
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 33(2)
There has been renewed interest of late in the role of modeling-based formation (MBF) during osteoporosis therapy. Here we describe early effects of an established anabolic (teriparatide) versus antiresorptive (denosumab) agent on remodeling-based fo
Autor:
David L. Kendler, Grattan Woodson, Hua Zhou, Christopher Recknor, David W. Dempster, Robert R. Recker, Robert Lindsay, D. Sudhaker Rao, E. Michael Lewiecki, Kathleen A. Taylor, Michael A. Bolognese, Boris Janos, Valerie A Ruff, Paul D. Miller, Xiaohai Wan, Jacques P. Brown, Neil Binkley, David A. Hanley
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 97:2799-2808
Recent studies on the mechanism of action (MOA) of bone-active drugs have rekindled interest in how to present and interpret dynamic histomorphometric parameters of bone remodeling.We compared the effects of an established anabolic agent, teriparatid
Autor:
David W, Dempster, Paul, Roschger, Barbara M, Misof, Hua, Zhou, Eleftherios P, Paschalis, Jahangir, Alam, Valerie A, Ruff, Klaus, Klaushofer, Kathleen A, Taylor
Publikováno v:
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 31(8)
The Skeletal Histomorphometry in Patients on Teriparatide or Zoledronic Acid Therapy (SHOTZ) study assessed the progressive effects of teriparatide (TPTD) and zoledronic acid (ZOL) on bone remodeling and material properties in postmenopausal women wi
Changes observed in radionuclide bone scans during and after teriparatide treatment for osteoporosis
Autor:
Amelia E. B. Moore, Xiaohai Wan, Glen M. Blake, Valerie A Ruff, Asad E. Rana, Kathleen A. Taylor, Ignac Fogelman
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging
Purpose Visual changes on radionuclide bone scans have been reported with teriparatide treatment. To assess this, serial studies were evaluated and quantified in ten postmenopausal women with osteoporosis treated with teriparatide (20 μg/day subcuta
Publikováno v:
Osteoporosis International. 23:1445-1452
The prospective, observational Direct Assessment of Nonvertebral Fracture in the Community Experience (DANCE) study shows that, among patients with risk factors for osteoporosis, women are more likely to be screened and to receive appropriate treatme